Luitpold Pharmaceuticals, Inc.

Phoenix Pharmalabs Inc, based in Providence, UT, is a pre-clinical pharmaceutical company dedicated to developing potent pain therapies with minimal risk of addiction and serious side effects. Their lead candidate, PPL-138, offers 100 times the potency of morphine with low abuse potential and no respiratory depression, while their second drug candidate, PPL-103, shows promise for treating addiction and pain with reduced opioid side effects. With over $23 million in funding from sources like the U.S. Army and NIH NIDA, Phoenix Pharmalabs aims to address the unmet medical need for safe pain management by creating drugs that provide effective pain relief without the harmful consequences associated with traditional opioids. Their innovative approach targets the $30 billion opioid therapeutics market, offering hope for a safer alternative to current pain management options.Generated from the website

Bard Access Systems is one of the leading companies that offers a range of vascular access devices in the United States. It manufactures and sells medical devices that are used in circulatory and other select systems. The company provides central venous catheters in a variety of models. Bard Access Systems offers a range of ports and feeding devices. It also provides a variety of ultrasound and drainage products. The company offers a range of accessories, such as tunnelers, suture wings, catheter clamps, injection caps and replacement connectors. Bard Access Systems has a staff of more than 300 employees. It administers the Assessment Advantage program and provides a variety of midline and dialysis catheters.